The NPC1 gene is a target in drug development because modulating its function can potentially treat or prevent the accumulation of toxic lipids in cells. Researchers are exploring compounds that can enhance or mimic NPC1 activity to treat lipid storage disorders, which highlights the gene's significance in developing pharmaceutical interventions for related diseases.
